Swiprosin-1/ EFhd2: from Immune Regulator to Personality and Brain Disorders
Kogias G., Kornhuber J., Reimer D., Mielenz D., Müller C.
Neurosignals 2019;27(S1):1-19
HTML PDF https://doi.org/10.33594/000000179
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis
Walter S., Gulbins E., Halmer R., Jahromi N., Becker K., Schottek A., Blatti C., Davies L., Schnoeder L., Bertsch T., Engelhardt B., Fassbender K.
Neurosignals 2019;27(S1):20-31
HTML PDF https://doi.org/10.33594/000000183
The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke Therapies
Mohamud Yusuf A., Hagemann N., Hermann D.
Neurosignals 2019;27(S1):32-43
HTML PDF https://doi.org/10.33594/000000184
Interferon in the CNS
Bhat H., Lang K., Hardt C., Lang J.
Neurosignals 2019;27(S1):44-53
HTML PDF https://doi.org/10.33594/000000197
Sphingomyelin Synthases in Neuropsychiatric Health and Disease
Mühle C., Canalejas R., Kornhuber J.
Neurosignals 2019;27:54-76
HTML PDF https://doi.org/10.33594/000000200